MUC3A mutation is associated with poor overall survival in chronic myeloid leukemia [52] and overexpression of MUC3A enhances the metastasis, which showed poor prognosis in gastric cancer and non-small cell lung cancer [53, 54]. Here, MUC3A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.